Filters: keyword is Erythrocytes [Clear All Filters]
- 1999
A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine,
J Pharmacokinet Biopharm, vol. 27, no. 3, pp. 257-81.
- 1998
Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine,
J Pharmacol Exp Ther, vol. 286, no. 1, pp. 142-9.
- 1997
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates,
Br J Clin Pharmacol, vol. 43, no. 6, pp. 603-12.
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations,
Eur J Clin Pharmacol, vol. 53, no. 1, pp. 57-63.
- 1996
The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine,
Br J Clin Pharmacol, vol. 42, no. 5, pp. 605-13.
- 1992
Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport,
Pharm Weekbl Sci, vol. 14, no. 6, pp. 338-48.
